| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Soft Tissue Neoplasms | 59 | 2023 | 1363 | 10.870 |
Why?
|
| Immunohistochemistry | 168 | 2023 | 11360 | 7.860 |
Why?
|
| Gastrointestinal Stromal Tumors | 29 | 2022 | 646 | 5.710 |
Why?
|
| Sarcoma | 43 | 2023 | 1898 | 5.520 |
Why?
|
| Succinate Dehydrogenase | 13 | 2022 | 146 | 3.570 |
Why?
|
| Gastrointestinal Neoplasms | 20 | 2023 | 991 | 3.320 |
Why?
|
| Proto-Oncogene Proteins c-kit | 30 | 2020 | 780 | 2.780 |
Why?
|
| Fibrosarcoma | 10 | 2023 | 345 | 2.520 |
Why?
|
| Gene Fusion | 9 | 2021 | 371 | 2.330 |
Why?
|
| Epithelioid Cells | 10 | 2021 | 71 | 2.210 |
Why?
|
| Molecular Diagnostic Techniques | 9 | 2021 | 602 | 2.200 |
Why?
|
| Bone Neoplasms | 19 | 2023 | 2529 | 2.190 |
Why?
|
| Gene Rearrangement | 16 | 2023 | 1179 | 2.180 |
Why?
|
| Hemangioendothelioma, Epithelioid | 5 | 2021 | 54 | 2.160 |
Why?
|
| Diagnosis, Differential | 70 | 2023 | 12954 | 2.100 |
Why?
|
| Adenocarcinoma | 32 | 2023 | 6363 | 1.910 |
Why?
|
| Histiocytoma, Benign Fibrous | 4 | 2019 | 109 | 1.820 |
Why?
|
| Stomach Neoplasms | 9 | 2023 | 1332 | 1.810 |
Why?
|
| Sarcoma, Synovial | 9 | 2020 | 167 | 1.780 |
Why?
|
| Nerve Sheath Neoplasms | 8 | 2021 | 191 | 1.770 |
Why?
|
| In Situ Hybridization, Fluorescence | 36 | 2023 | 2649 | 1.760 |
Why?
|
| Transcription Factors | 33 | 2023 | 12209 | 1.700 |
Why?
|
| Vascular Neoplasms | 6 | 2021 | 175 | 1.690 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 13 | 2023 | 1660 | 1.670 |
Why?
|
| Oncogene Proteins, Fusion | 19 | 2023 | 1581 | 1.630 |
Why?
|
| Liposarcoma | 13 | 2023 | 333 | 1.620 |
Why?
|
| Leiomyosarcoma | 12 | 2022 | 477 | 1.620 |
Why?
|
| Liposarcoma, Myxoid | 5 | 2023 | 67 | 1.570 |
Why?
|
| Mast Cells | 10 | 2023 | 1544 | 1.510 |
Why?
|
| Homeodomain Proteins | 12 | 2021 | 2419 | 1.500 |
Why?
|
| SOXB1 Transcription Factors | 9 | 2022 | 284 | 1.500 |
Why?
|
| Neoplasm Proteins | 16 | 2021 | 3706 | 1.470 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 11 | 2022 | 379 | 1.390 |
Why?
|
| Neoplasms, Unknown Primary | 3 | 2022 | 104 | 1.380 |
Why?
|
| Skin Neoplasms | 18 | 2023 | 5691 | 1.380 |
Why?
|
| Rhabdomyosarcoma | 4 | 2021 | 384 | 1.320 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 5 | 2021 | 75 | 1.280 |
Why?
|
| Esophageal Neoplasms | 12 | 2021 | 1585 | 1.280 |
Why?
|
| Dermatofibrosarcoma | 5 | 2021 | 63 | 1.250 |
Why?
|
| Neurilemmoma | 5 | 2021 | 547 | 1.250 |
Why?
|
| Mastocytosis, Systemic | 5 | 2018 | 100 | 1.240 |
Why?
|
| Abdominal Neoplasms | 6 | 2014 | 292 | 1.230 |
Why?
|
| Solitary Fibrous Tumors | 5 | 2016 | 72 | 1.210 |
Why?
|
| Mutation | 50 | 2023 | 29777 | 1.160 |
Why?
|
| Antibodies, Monoclonal | 21 | 2021 | 9272 | 1.150 |
Why?
|
| Lipoma | 6 | 2023 | 334 | 1.140 |
Why?
|
| Barrett Esophagus | 9 | 2021 | 494 | 1.140 |
Why?
|
| Trans-Activators | 9 | 2021 | 2927 | 1.140 |
Why?
|
| Humans | 385 | 2023 | 743811 | 1.120 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 4 | 2017 | 30 | 1.090 |
Why?
|
| Neoplasms, Fibrous Tissue | 3 | 2022 | 25 | 1.090 |
Why?
|
| Pathology, Molecular | 3 | 2019 | 326 | 1.090 |
Why?
|
| Carcinoma, Acinar Cell | 3 | 2023 | 61 | 1.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 5 | 2020 | 735 | 1.050 |
Why?
|
| Middle Aged | 194 | 2023 | 213241 | 1.030 |
Why?
|
| Mesenchymoma | 2 | 2022 | 47 | 1.020 |
Why?
|
| Histiocytic Sarcoma | 5 | 2019 | 44 | 0.990 |
Why?
|
| Bile Duct Neoplasms | 4 | 2022 | 567 | 0.980 |
Why?
|
| Sarcoma, Small Cell | 4 | 2023 | 22 | 0.980 |
Why?
|
| Rhabdoid Tumor | 2 | 2020 | 212 | 0.980 |
Why?
|
| Predictive Value of Tests | 32 | 2022 | 15067 | 0.970 |
Why?
|
| Repressor Proteins | 9 | 2021 | 3024 | 0.960 |
Why?
|
| Pancreatic Neoplasms | 14 | 2023 | 5264 | 0.950 |
Why?
|
| Cholangiocarcinoma | 4 | 2022 | 516 | 0.950 |
Why?
|
| Histones | 8 | 2020 | 2598 | 0.940 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2020 | 4552 | 0.930 |
Why?
|
| Carcinoma | 10 | 2023 | 2375 | 0.930 |
Why?
|
| Adult | 174 | 2023 | 213889 | 0.930 |
Why?
|
| Salivary Gland Neoplasms | 4 | 2023 | 298 | 0.930 |
Why?
|
| Aged | 157 | 2023 | 163178 | 0.930 |
Why?
|
| Male | 218 | 2023 | 349776 | 0.930 |
Why?
|
| Mucin-4 | 4 | 2016 | 37 | 0.900 |
Why?
|
| Female | 227 | 2023 | 380020 | 0.900 |
Why?
|
| Chondroblastoma | 2 | 2020 | 50 | 0.890 |
Why?
|
| Calmodulin-Binding Proteins | 8 | 2022 | 250 | 0.890 |
Why?
|
| Terminology as Topic | 5 | 2019 | 1546 | 0.850 |
Why?
|
| Sarcoma, Kaposi | 2 | 2023 | 370 | 0.850 |
Why?
|
| Mastocytosis | 4 | 2021 | 160 | 0.850 |
Why?
|
| Nuclear Proteins | 21 | 2021 | 5854 | 0.840 |
Why?
|
| Hemangiosarcoma | 6 | 2019 | 239 | 0.820 |
Why?
|
| Young Adult | 74 | 2023 | 56392 | 0.810 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2021 | 705 | 0.810 |
Why?
|
| Glomus Tumor | 1 | 2022 | 66 | 0.810 |
Why?
|
| Stromal Cells | 7 | 2021 | 1356 | 0.780 |
Why?
|
| Herpesvirus 8, Human | 1 | 2023 | 258 | 0.780 |
Why?
|
| Neoplasm Recurrence, Local | 31 | 2022 | 9239 | 0.770 |
Why?
|
| Transcription Factor CHOP | 1 | 2021 | 73 | 0.770 |
Why?
|
| Prognosis | 47 | 2023 | 29052 | 0.770 |
Why?
|
| DNA Mutational Analysis | 25 | 2022 | 4183 | 0.770 |
Why?
|
| Biopsy | 27 | 2023 | 6750 | 0.750 |
Why?
|
| Myofibroma | 3 | 2019 | 50 | 0.730 |
Why?
|
| Intestinal Mucosa | 9 | 2021 | 3038 | 0.730 |
Why?
|
| Osteosarcoma | 4 | 2022 | 881 | 0.720 |
Why?
|
| Sensitivity and Specificity | 28 | 2021 | 14714 | 0.710 |
Why?
|
| Neoplastic Syndromes, Hereditary | 3 | 2017 | 241 | 0.710 |
Why?
|
| ras Proteins | 5 | 2019 | 1059 | 0.710 |
Why?
|
| Neurofibrosarcoma | 1 | 2019 | 24 | 0.700 |
Why?
|
| Colorectal Neoplasms | 12 | 2021 | 6773 | 0.700 |
Why?
|
| Adolescent | 70 | 2023 | 85729 | 0.690 |
Why?
|
| Receptor, trkA | 3 | 2022 | 164 | 0.690 |
Why?
|
| Retinal Neoplasms | 1 | 2021 | 143 | 0.690 |
Why?
|
| Aged, 80 and over | 73 | 2022 | 57744 | 0.670 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2018 | 234 | 0.670 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2014 | 310 | 0.670 |
Why?
|
| Myoepithelioma | 4 | 2013 | 43 | 0.670 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 315 | 0.670 |
Why?
|
| Lung Neoplasms | 21 | 2022 | 13112 | 0.670 |
Why?
|
| Esophagogastric Junction | 1 | 2021 | 313 | 0.660 |
Why?
|
| Retinoblastoma | 1 | 2021 | 316 | 0.650 |
Why?
|
| WT1 Proteins | 2 | 2016 | 178 | 0.640 |
Why?
|
| Paired Box Transcription Factors | 4 | 2015 | 214 | 0.640 |
Why?
|
| Carcinoid Tumor | 3 | 2010 | 235 | 0.640 |
Why?
|
| Intestine, Small | 2 | 2021 | 1240 | 0.640 |
Why?
|
| DNA-Binding Proteins | 17 | 2023 | 9648 | 0.630 |
Why?
|
| Urticaria Pigmentosa | 2 | 2008 | 17 | 0.630 |
Why?
|
| Retroperitoneal Neoplasms | 6 | 2015 | 340 | 0.620 |
Why?
|
| Cytodiagnosis | 5 | 2017 | 435 | 0.620 |
Why?
|
| Hemangioendothelioma | 3 | 2019 | 121 | 0.620 |
Why?
|
| Pleural Neoplasms | 5 | 2022 | 608 | 0.620 |
Why?
|
| Keratins | 6 | 2021 | 515 | 0.580 |
Why?
|
| Uterine Neoplasms | 8 | 2022 | 1513 | 0.580 |
Why?
|
| Chromosomes, Human | 3 | 2017 | 457 | 0.580 |
Why?
|
| Electron Transport Complex II | 3 | 2013 | 48 | 0.570 |
Why?
|
| Myofibroblasts | 4 | 2016 | 222 | 0.570 |
Why?
|
| Intestinal Neoplasms | 4 | 2023 | 319 | 0.570 |
Why?
|
| Cell Nucleus | 10 | 2021 | 2969 | 0.570 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2015 | 2453 | 0.570 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2016 | 76 | 0.570 |
Why?
|
| STAT6 Transcription Factor | 2 | 2013 | 199 | 0.560 |
Why?
|
| Neuroendocrine Tumors | 6 | 2023 | 594 | 0.550 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.540 |
Why?
|
| Gastrointestinal Diseases | 3 | 2021 | 1171 | 0.540 |
Why?
|
| Endocrine System Diseases | 1 | 2018 | 247 | 0.540 |
Why?
|
| Melanoma | 8 | 2023 | 5508 | 0.530 |
Why?
|
| Nuclear Envelope | 2 | 2021 | 171 | 0.520 |
Why?
|
| Precancerous Conditions | 5 | 2022 | 975 | 0.520 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 4 | 2022 | 501 | 0.520 |
Why?
|
| Sclerosis | 3 | 2014 | 213 | 0.520 |
Why?
|
| Child | 47 | 2023 | 77637 | 0.520 |
Why?
|
| Granuloma, Plasma Cell | 4 | 2011 | 84 | 0.520 |
Why?
|
| Neoplasms, Multiple Primary | 4 | 2014 | 604 | 0.520 |
Why?
|
| Calcium-Binding Proteins | 3 | 2019 | 1081 | 0.510 |
Why?
|
| Cell Differentiation | 10 | 2019 | 11478 | 0.510 |
Why?
|
| Hamartoma | 2 | 2009 | 238 | 0.510 |
Why?
|
| Antibody Specificity | 5 | 2021 | 1095 | 0.510 |
Why?
|
| RNA-Binding Protein FUS | 2 | 2012 | 72 | 0.510 |
Why?
|
| Paraganglioma | 3 | 2014 | 143 | 0.500 |
Why?
|
| High-Throughput Nucleotide Sequencing | 17 | 2021 | 3591 | 0.500 |
Why?
|
| Tryptases | 4 | 2021 | 190 | 0.500 |
Why?
|
| Adenocarcinoma, Mucinous | 5 | 2016 | 507 | 0.490 |
Why?
|
| Biopsy, Fine-Needle | 9 | 2018 | 1094 | 0.490 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 1524 | 0.490 |
Why?
|
| Head and Neck Neoplasms | 6 | 2020 | 2736 | 0.490 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 2 | 2020 | 37 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2017 | 575 | 0.490 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2013 | 514 | 0.480 |
Why?
|
| Mucous Membrane | 6 | 2023 | 669 | 0.480 |
Why?
|
| Matrix Attachment Region Binding Proteins | 2 | 2014 | 44 | 0.480 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 224 | 0.480 |
Why?
|
| Membrane Glycoproteins | 4 | 2009 | 3769 | 0.470 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2023 | 332 | 0.470 |
Why?
|
| Smooth Muscle Tumor | 2 | 2016 | 67 | 0.470 |
Why?
|
| DNA, Neoplasm | 7 | 2013 | 1758 | 0.470 |
Why?
|
| Esophagus | 4 | 2011 | 1019 | 0.470 |
Why?
|
| Tissue Array Analysis | 9 | 2022 | 553 | 0.460 |
Why?
|
| Skin | 7 | 2018 | 4372 | 0.460 |
Why?
|
| Molecular Targeted Therapy | 5 | 2021 | 2727 | 0.450 |
Why?
|
| Adenoma | 5 | 2012 | 2173 | 0.450 |
Why?
|
| Histiocytosis, Langerhans-Cell | 4 | 2018 | 171 | 0.450 |
Why?
|
| Cell Dedifferentiation | 2 | 2013 | 135 | 0.450 |
Why?
|
| Staining and Labeling | 6 | 2017 | 1098 | 0.450 |
Why?
|
| Mast-Cell Sarcoma | 1 | 2012 | 47 | 0.450 |
Why?
|
| Testicular Neoplasms | 4 | 2022 | 803 | 0.440 |
Why?
|
| Seminoma | 3 | 2011 | 139 | 0.440 |
Why?
|
| Neuroblastoma | 2 | 2018 | 1226 | 0.430 |
Why?
|
| Isocitrate Dehydrogenase | 6 | 2021 | 871 | 0.430 |
Why?
|
| Purine-Nucleoside Phosphorylase | 2 | 2023 | 27 | 0.430 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2017 | 547 | 0.430 |
Why?
|
| DNA Methylation | 10 | 2019 | 4286 | 0.430 |
Why?
|
| RNA-Binding Proteins | 5 | 2018 | 1900 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-ets | 4 | 2019 | 318 | 0.420 |
Why?
|
| Neoplasms | 8 | 2021 | 21675 | 0.420 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 332 | 0.420 |
Why?
|
| Proto-Oncogene Proteins B-raf | 7 | 2018 | 2039 | 0.420 |
Why?
|
| Kidney Neoplasms | 5 | 2017 | 4260 | 0.410 |
Why?
|
| Cytosine | 1 | 2013 | 216 | 0.410 |
Why?
|
| Dendritic Cells, Follicular | 2 | 2009 | 53 | 0.410 |
Why?
|
| Cyclin-Dependent Kinase 4 | 6 | 2022 | 539 | 0.410 |
Why?
|
| Colonic Polyps | 2 | 2009 | 542 | 0.410 |
Why?
|
| Lymph Nodes | 8 | 2021 | 3476 | 0.400 |
Why?
|
| Dermatology | 1 | 2022 | 872 | 0.400 |
Why?
|
| Membrane Proteins | 10 | 2013 | 7880 | 0.400 |
Why?
|
| Piperazines | 11 | 2015 | 2487 | 0.400 |
Why?
|
| RNA-Binding Protein EWS | 6 | 2023 | 216 | 0.390 |
Why?
|
| Immunoenzyme Techniques | 9 | 2016 | 1799 | 0.390 |
Why?
|
| Fibroma | 5 | 2016 | 212 | 0.390 |
Why?
|
| Mutant Proteins | 1 | 2013 | 500 | 0.390 |
Why?
|
| Receptors, Steroid | 2 | 2023 | 155 | 0.390 |
Why?
|
| Carcinoma, Medullary | 1 | 2011 | 123 | 0.380 |
Why?
|
| NF-kappa B | 2 | 2019 | 2500 | 0.380 |
Why?
|
| Neoadjuvant Therapy | 6 | 2021 | 2727 | 0.380 |
Why?
|
| Eosinophilic Esophagitis | 3 | 2023 | 168 | 0.380 |
Why?
|
| Actins | 6 | 2022 | 2121 | 0.380 |
Why?
|
| Gastrointestinal Tract | 3 | 2023 | 814 | 0.380 |
Why?
|
| Retinoblastoma Binding Proteins | 2 | 2021 | 98 | 0.380 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2011 | 111 | 0.370 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2010 | 22 | 0.370 |
Why?
|
| Cytogenetic Analysis | 5 | 2017 | 294 | 0.370 |
Why?
|
| Adenoma, Islet Cell | 1 | 2010 | 82 | 0.370 |
Why?
|
| In Situ Hybridization | 6 | 2021 | 1952 | 0.370 |
Why?
|
| Retinoblastoma Protein | 3 | 2015 | 705 | 0.370 |
Why?
|
| Hemosiderosis | 1 | 2010 | 71 | 0.360 |
Why?
|
| DNA Helicases | 4 | 2020 | 861 | 0.360 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2021 | 8430 | 0.360 |
Why?
|
| Molecular Biology | 3 | 2023 | 595 | 0.360 |
Why?
|
| Melanoma-Specific Antigens | 4 | 2021 | 80 | 0.360 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2021 | 1142 | 0.360 |
Why?
|
| Thyroid Neoplasms | 4 | 2022 | 2282 | 0.360 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2013 | 740 | 0.360 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2022 | 2027 | 0.360 |
Why?
|
| Thoracic Neoplasms | 4 | 2020 | 268 | 0.360 |
Why?
|
| Stomach | 1 | 2014 | 697 | 0.350 |
Why?
|
| Gene Amplification | 6 | 2019 | 1063 | 0.350 |
Why?
|
| Early Detection of Cancer | 2 | 2021 | 3089 | 0.340 |
Why?
|
| Genetic Testing | 6 | 2021 | 3439 | 0.340 |
Why?
|
| Pyrimidines | 10 | 2013 | 2945 | 0.340 |
Why?
|
| Chondrosarcoma | 4 | 2023 | 309 | 0.330 |
Why?
|
| Placenta Diseases | 2 | 2021 | 199 | 0.330 |
Why?
|
| Extremities | 5 | 2016 | 867 | 0.330 |
Why?
|
| Esophagectomy | 5 | 2021 | 447 | 0.320 |
Why?
|
| Histiocytic Disorders, Malignant | 3 | 2018 | 16 | 0.320 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 445 | 0.320 |
Why?
|
| Angiofibroma | 2 | 2023 | 68 | 0.320 |
Why?
|
| Schwann Cells | 1 | 2009 | 196 | 0.320 |
Why?
|
| Ovarian Neoplasms | 5 | 2018 | 4839 | 0.320 |
Why?
|
| Child, Preschool | 18 | 2021 | 40964 | 0.320 |
Why?
|
| Sarcoma, Clear Cell | 2 | 2023 | 76 | 0.320 |
Why?
|
| Adipocytes | 3 | 2017 | 1182 | 0.310 |
Why?
|
| Thyroid Diseases | 1 | 2011 | 379 | 0.310 |
Why?
|
| Infant | 22 | 2020 | 35122 | 0.310 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2022 | 295 | 0.310 |
Why?
|
| Muscle, Smooth | 3 | 2015 | 934 | 0.310 |
Why?
|
| Neuroma | 1 | 2009 | 103 | 0.310 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2020 | 4033 | 0.300 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2016 | 1691 | 0.300 |
Why?
|
| Maxillary Sinus Neoplasms | 2 | 2018 | 40 | 0.300 |
Why?
|
| Fumarate Hydratase | 2 | 2018 | 47 | 0.300 |
Why?
|
| Neurothekeoma | 1 | 2007 | 7 | 0.300 |
Why?
|
| Chromosome Aberrations | 5 | 2019 | 1811 | 0.300 |
Why?
|
| Osteoblasts | 1 | 2013 | 1164 | 0.300 |
Why?
|
| Mucins | 2 | 2012 | 564 | 0.300 |
Why?
|
| Rectal Neoplasms | 4 | 2021 | 1205 | 0.300 |
Why?
|
| Phenotype | 14 | 2021 | 16361 | 0.300 |
Why?
|
| Retrospective Studies | 45 | 2023 | 77410 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2013 | 462 | 0.290 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 4 | 2017 | 379 | 0.290 |
Why?
|
| DNA Mismatch Repair | 3 | 2021 | 426 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 4 | 2013 | 381 | 0.280 |
Why?
|
| Sweat Gland Neoplasms | 2 | 2020 | 108 | 0.280 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2021 | 17439 | 0.280 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2014 | 524 | 0.280 |
Why?
|
| Neoplasm Staging | 19 | 2021 | 11036 | 0.280 |
Why?
|
| S100 Proteins | 5 | 2012 | 259 | 0.280 |
Why?
|
| Liver Neoplasms | 8 | 2019 | 4251 | 0.280 |
Why?
|
| Benzamides | 10 | 2013 | 1383 | 0.270 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2017 | 3142 | 0.270 |
Why?
|
| Hemangioma | 2 | 2022 | 738 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2020 | 4749 | 0.260 |
Why?
|
| Diagnostic Imaging | 6 | 2016 | 3503 | 0.260 |
Why?
|
| Histiocytoma, Malignant Fibrous | 2 | 2019 | 63 | 0.260 |
Why?
|
| Lymphangioma, Cystic | 1 | 2005 | 34 | 0.260 |
Why?
|
| Antigens, CD34 | 8 | 2013 | 658 | 0.260 |
Why?
|
| Fasciitis | 1 | 2006 | 65 | 0.260 |
Why?
|
| Translocation, Genetic | 6 | 2018 | 1420 | 0.260 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2023 | 484 | 0.260 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 6 | 2013 | 693 | 0.250 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 1637 | 0.250 |
Why?
|
| Follow-Up Studies | 25 | 2021 | 39001 | 0.250 |
Why?
|
| Thyroid Gland | 1 | 2011 | 1173 | 0.250 |
Why?
|
| Disease-Free Survival | 15 | 2019 | 6895 | 0.250 |
Why?
|
| Mastocytosis, Cutaneous | 2 | 2015 | 14 | 0.250 |
Why?
|
| Mucin-1 | 5 | 2009 | 544 | 0.240 |
Why?
|
| Neoplasm Metastasis | 14 | 2021 | 4848 | 0.240 |
Why?
|
| Antigens, Neoplasm | 5 | 2023 | 1988 | 0.240 |
Why?
|
| Neuroectodermal Tumors, Primitive | 3 | 2013 | 140 | 0.240 |
Why?
|
| Cell Lineage | 4 | 2021 | 2506 | 0.240 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2021 | 5532 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2019 | 988 | 0.240 |
Why?
|
| Angiomyolipoma | 1 | 2006 | 190 | 0.240 |
Why?
|
| Muscle Proteins | 1 | 2009 | 1158 | 0.240 |
Why?
|
| Sequence Analysis, RNA | 4 | 2021 | 2009 | 0.240 |
Why?
|
| Histiocytosis, Sinus | 2 | 2016 | 47 | 0.240 |
Why?
|
| Anus Neoplasms | 2 | 2019 | 332 | 0.240 |
Why?
|
| Langerhans Cells | 2 | 2017 | 173 | 0.230 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 1364 | 0.230 |
Why?
|
| Neurofibromatosis 1 | 1 | 2009 | 570 | 0.230 |
Why?
|
| Treatment Outcome | 35 | 2021 | 63042 | 0.230 |
Why?
|
| Endometrial Neoplasms | 3 | 2020 | 1350 | 0.230 |
Why?
|
| Reproducibility of Results | 14 | 2022 | 19894 | 0.230 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2023 | 202 | 0.230 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2016 | 5170 | 0.230 |
Why?
|
| Neuroectodermal Tumors | 1 | 2023 | 27 | 0.230 |
Why?
|
| Photosensitizing Agents | 1 | 2007 | 602 | 0.230 |
Why?
|
| Genes, p53 | 4 | 2021 | 755 | 0.230 |
Why?
|
| Microsatellite Instability | 4 | 2016 | 684 | 0.230 |
Why?
|
| Peritoneal Neoplasms | 4 | 2014 | 665 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 4463 | 0.220 |
Why?
|
| Laboratories | 2 | 2017 | 462 | 0.220 |
Why?
|
| Epithelium | 3 | 2014 | 1679 | 0.220 |
Why?
|
| Annexins | 1 | 2022 | 38 | 0.220 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2020 | 388 | 0.220 |
Why?
|
| Desmin | 4 | 2015 | 130 | 0.220 |
Why?
|
| Cross Reactions | 4 | 2018 | 841 | 0.220 |
Why?
|
| Gastrectomy | 2 | 2021 | 663 | 0.220 |
Why?
|
| Mesothelioma | 3 | 2022 | 818 | 0.210 |
Why?
|
| Synaptophysin | 1 | 2022 | 141 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2021 | 251 | 0.210 |
Why?
|
| Gene Expression | 6 | 2021 | 7793 | 0.210 |
Why?
|
| Brain Neoplasms | 8 | 2021 | 8856 | 0.210 |
Why?
|
| Oncogenes | 2 | 2019 | 1265 | 0.210 |
Why?
|
| Claudins | 1 | 2022 | 111 | 0.210 |
Why?
|
| Thymoma | 1 | 2023 | 186 | 0.200 |
Why?
|
| Colonic Neoplasms | 4 | 2019 | 2542 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2022 | 2018 | 0.200 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2021 | 45 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 1861 | 0.200 |
Why?
|
| Carcinoma, Verrucous | 1 | 2021 | 23 | 0.200 |
Why?
|
| Joint Diseases | 1 | 2006 | 479 | 0.200 |
Why?
|
| Cyclin D1 | 2 | 2017 | 463 | 0.200 |
Why?
|
| Keratin-7 | 1 | 2021 | 57 | 0.200 |
Why?
|
| Inflammation | 6 | 2021 | 10629 | 0.200 |
Why?
|
| Photochemotherapy | 1 | 2007 | 808 | 0.200 |
Why?
|
| Oncogene Proteins | 3 | 2016 | 749 | 0.190 |
Why?
|
| Karyotyping | 4 | 2011 | 1243 | 0.190 |
Why?
|
| Colonoscopy | 4 | 2014 | 1367 | 0.190 |
Why?
|
| PAX7 Transcription Factor | 2 | 2018 | 53 | 0.190 |
Why?
|
| Chondrosarcoma, Mesenchymal | 1 | 2020 | 15 | 0.190 |
Why?
|
| Thymus Neoplasms | 1 | 2023 | 268 | 0.190 |
Why?
|
| Eccrine Porocarcinoma | 1 | 2020 | 15 | 0.190 |
Why?
|
| Neoplasms, Muscle Tissue | 2 | 2012 | 83 | 0.190 |
Why?
|
| Chloride Channels | 3 | 2011 | 227 | 0.190 |
Why?
|
| Zebrafish Proteins | 2 | 2018 | 1005 | 0.190 |
Why?
|
| Endoscopy, Gastrointestinal | 7 | 2018 | 868 | 0.190 |
Why?
|
| Germ-Line Mutation | 6 | 2018 | 1787 | 0.190 |
Why?
|
| Lymphadenitis | 1 | 2021 | 98 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2023 | 35409 | 0.190 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2022 | 2944 | 0.180 |
Why?
|
| Gene Expression Profiling | 9 | 2018 | 9440 | 0.180 |
Why?
|
| Osteomalacia | 1 | 2020 | 53 | 0.180 |
Why?
|
| Receptors, Somatostatin | 1 | 2021 | 129 | 0.180 |
Why?
|
| SOXE Transcription Factors | 2 | 2018 | 57 | 0.180 |
Why?
|
| Pelvic Neoplasms | 1 | 2022 | 254 | 0.180 |
Why?
|
| Appendix | 1 | 2021 | 110 | 0.180 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 188 | 0.180 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 165 | 0.180 |
Why?
|
| Vaginal Neoplasms | 1 | 2020 | 105 | 0.180 |
Why?
|
| beta Catenin | 4 | 2021 | 1060 | 0.180 |
Why?
|
| Survival Rate | 14 | 2021 | 12786 | 0.180 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2021 | 97 | 0.180 |
Why?
|
| Fibromatosis, Aggressive | 3 | 2016 | 118 | 0.180 |
Why?
|
| Loss of Heterozygosity | 3 | 2017 | 684 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 9 | 2019 | 3617 | 0.180 |
Why?
|
| Chromatin | 3 | 2022 | 2931 | 0.180 |
Why?
|
| Sucrose | 1 | 2020 | 164 | 0.170 |
Why?
|
| DNA | 2 | 2007 | 7295 | 0.170 |
Why?
|
| Lymphatic Metastasis | 6 | 2018 | 2924 | 0.170 |
Why?
|
| Hypophosphatemia | 1 | 2020 | 86 | 0.170 |
Why?
|
| MutS Homolog 2 Protein | 3 | 2019 | 200 | 0.170 |
Why?
|
| Cell Proliferation | 5 | 2017 | 10477 | 0.170 |
Why?
|
| Expert Testimony | 2 | 2019 | 355 | 0.170 |
Why?
|
| Leiomyoma | 2 | 2016 | 730 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 634 | 0.170 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.170 |
Why?
|
| Colectomy | 1 | 2004 | 680 | 0.170 |
Why?
|
| MART-1 Antigen | 3 | 2008 | 64 | 0.170 |
Why?
|
| Dermatitis, Atopic | 2 | 2018 | 654 | 0.170 |
Why?
|
| Foot Diseases | 1 | 2020 | 143 | 0.170 |
Why?
|
| Clusterin | 2 | 2009 | 72 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 2942 | 0.170 |
Why?
|
| Diarrhea | 4 | 2014 | 1348 | 0.170 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2009 | 223 | 0.170 |
Why?
|
| Collagen Type VI | 1 | 2018 | 26 | 0.170 |
Why?
|
| Receptor, trkC | 1 | 2018 | 68 | 0.160 |
Why?
|
| Albumins | 1 | 2021 | 568 | 0.160 |
Why?
|
| Histiocytes | 2 | 2010 | 103 | 0.160 |
Why?
|
| Histiocytosis | 1 | 2018 | 40 | 0.160 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2019 | 200 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 571 | 0.160 |
Why?
|
| Placenta | 3 | 2022 | 1699 | 0.160 |
Why?
|
| Carcinoma, Embryonal | 2 | 2009 | 38 | 0.160 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 110 | 0.160 |
Why?
|
| Contractile Proteins | 1 | 2019 | 246 | 0.160 |
Why?
|
| Radioimmunotherapy | 1 | 1998 | 91 | 0.160 |
Why?
|
| Neoplasm, Residual | 4 | 2017 | 973 | 0.160 |
Why?
|
| Intestines | 1 | 2007 | 1923 | 0.160 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 109 | 0.160 |
Why?
|
| Stillbirth | 1 | 2021 | 346 | 0.160 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 16674 | 0.160 |
Why?
|
| Supratentorial Neoplasms | 1 | 2019 | 160 | 0.160 |
Why?
|
| Duodenum | 1 | 2021 | 484 | 0.160 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 275 | 0.160 |
Why?
|
| Immunoblotting | 2 | 2020 | 1683 | 0.160 |
Why?
|
| Vulvar Neoplasms | 1 | 2020 | 272 | 0.160 |
Why?
|
| Dendritic Cell Sarcoma, Interdigitating | 1 | 2017 | 3 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2020 | 5230 | 0.150 |
Why?
|
| Immunoglobulin E | 3 | 2015 | 1463 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 2 | 2018 | 1376 | 0.150 |
Why?
|
| Vena Cava, Inferior | 2 | 2014 | 439 | 0.150 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2017 | 17 | 0.150 |
Why?
|
| Breast Neoplasms, Male | 1 | 2019 | 210 | 0.150 |
Why?
|
| Lymph Node Excision | 3 | 2021 | 1262 | 0.150 |
Why?
|
| Immunoprecipitation | 1 | 2020 | 906 | 0.150 |
Why?
|
| Amino Acid Substitution | 2 | 2013 | 1793 | 0.150 |
Why?
|
| Case-Control Studies | 8 | 2023 | 21733 | 0.150 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2021 | 690 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2019 | 6539 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2019 | 220 | 0.150 |
Why?
|
| Angiolipoma | 1 | 2017 | 13 | 0.150 |
Why?
|
| Intermediate Filament Proteins | 1 | 2018 | 269 | 0.150 |
Why?
|
| Rabbits | 3 | 2020 | 4894 | 0.150 |
Why?
|
| RNA | 3 | 2023 | 2748 | 0.150 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2018 | 116 | 0.150 |
Why?
|
| California | 1 | 2021 | 1402 | 0.150 |
Why?
|
| Pathology, Clinical | 2 | 2018 | 368 | 0.150 |
Why?
|
| Meningioma | 1 | 2006 | 1209 | 0.150 |
Why?
|
| Mycobacterium Infections | 1 | 2017 | 118 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2018 | 11524 | 0.140 |
Why?
|
| Heredity | 1 | 2017 | 154 | 0.140 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 7719 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2017 | 3917 | 0.140 |
Why?
|
| Time Factors | 13 | 2021 | 40038 | 0.140 |
Why?
|
| Anaphylaxis | 2 | 2015 | 746 | 0.140 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2017 | 117 | 0.140 |
Why?
|
| Interleukin-2 | 3 | 1999 | 1904 | 0.140 |
Why?
|
| HIV Infections | 1 | 2023 | 16715 | 0.140 |
Why?
|
| Meningeal Neoplasms | 1 | 2006 | 1241 | 0.140 |
Why?
|
| Antineoplastic Agents | 10 | 2014 | 13691 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2020 | 1097 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2005 | 1253 | 0.140 |
Why?
|
| Up-Regulation | 3 | 2017 | 4221 | 0.140 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 2 | 2013 | 105 | 0.140 |
Why?
|
| Genotype | 5 | 2015 | 12944 | 0.140 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2017 | 91 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 7 | 2016 | 6170 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 2916 | 0.140 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2016 | 23 | 0.140 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 198 | 0.140 |
Why?
|
| Myeloproliferative Disorders | 2 | 2020 | 606 | 0.140 |
Why?
|
| Ependymoma | 1 | 2019 | 334 | 0.140 |
Why?
|
| Heartburn | 1 | 2016 | 68 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 671 | 0.130 |
Why?
|
| Lung Injury | 1 | 2021 | 432 | 0.130 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2018 | 625 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2017 | 20121 | 0.130 |
Why?
|
| Sirolimus | 2 | 2021 | 1565 | 0.130 |
Why?
|
| Receptor, erbB-2 | 2 | 2019 | 2418 | 0.130 |
Why?
|
| Ki-67 Antigen | 3 | 2022 | 644 | 0.130 |
Why?
|
| Leiomyomatosis | 1 | 2016 | 70 | 0.130 |
Why?
|
| Cell Count | 3 | 2016 | 1855 | 0.130 |
Why?
|
| Wasp Venoms | 1 | 2015 | 18 | 0.130 |
Why?
|
| Dacarbazine | 2 | 2009 | 566 | 0.130 |
Why?
|
| Wasps | 1 | 2015 | 13 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1999 | 3772 | 0.130 |
Why?
|
| Asymptomatic Diseases | 2 | 2018 | 552 | 0.130 |
Why?
|
| Oncogene Fusion | 3 | 2021 | 99 | 0.130 |
Why?
|
| Protein Kinase C | 2 | 2014 | 1227 | 0.130 |
Why?
|
| Lymphokines | 1 | 2018 | 948 | 0.130 |
Why?
|
| Colitis, Ulcerative | 2 | 2004 | 1911 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 1213 | 0.130 |
Why?
|
| Axonemal Dyneins | 1 | 2014 | 24 | 0.130 |
Why?
|
| Risk Assessment | 7 | 2022 | 23327 | 0.130 |
Why?
|
| Radiopharmaceuticals | 5 | 2018 | 2647 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2015 | 78 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.130 |
Why?
|
| Boston | 4 | 2021 | 9310 | 0.130 |
Why?
|
| Human papillomavirus 18 | 1 | 2015 | 128 | 0.130 |
Why?
|
| World Health Organization | 1 | 2021 | 1317 | 0.130 |
Why?
|
| Mitotic Index | 3 | 2013 | 172 | 0.120 |
Why?
|
| Insect Bites and Stings | 1 | 2015 | 67 | 0.120 |
Why?
|
| Esophageal Stenosis | 1 | 2016 | 195 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 2017 | 373 | 0.120 |
Why?
|
| Germ Cells | 1 | 2018 | 629 | 0.120 |
Why?
|
| Indocyanine Green | 1 | 2016 | 240 | 0.120 |
Why?
|
| Colitis | 2 | 2013 | 1170 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 571 | 0.120 |
Why?
|
| Quality Control | 1 | 2017 | 841 | 0.120 |
Why?
|
| Metaplasia | 4 | 2021 | 313 | 0.120 |
Why?
|
| Pedigree | 3 | 2017 | 4643 | 0.120 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 669 | 0.120 |
Why?
|
| Bradyrhizobium | 1 | 2013 | 17 | 0.120 |
Why?
|
| Xanthomatosis | 1 | 2013 | 32 | 0.120 |
Why?
|
| Fetal Proteins | 1 | 2014 | 94 | 0.120 |
Why?
|
| Genes, Retinoblastoma | 1 | 2014 | 136 | 0.120 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 261 | 0.120 |
Why?
|
| Microarray Analysis | 2 | 2014 | 765 | 0.120 |
Why?
|
| Intestinal Polyposis | 1 | 2013 | 44 | 0.120 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2013 | 46 | 0.120 |
Why?
|
| Eosinophils | 2 | 2016 | 954 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 531 | 0.110 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2014 | 101 | 0.110 |
Why?
|
| Osteoblastoma | 1 | 2013 | 24 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2005 | 712 | 0.110 |
Why?
|
| HMGA2 Protein | 2 | 2011 | 123 | 0.110 |
Why?
|
| Algorithms | 4 | 2021 | 13869 | 0.110 |
Why?
|
| Paraffin Embedding | 2 | 2013 | 299 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2018 | 2016 | 0.110 |
Why?
|
| Rectum | 2 | 2017 | 904 | 0.110 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2015 | 214 | 0.110 |
Why?
|
| Genital Neoplasms, Male | 1 | 2013 | 74 | 0.110 |
Why?
|
| Oligodendroglioma | 1 | 2014 | 279 | 0.110 |
Why?
|
| Osteoma, Osteoid | 1 | 2013 | 80 | 0.110 |
Why?
|
| 5-Methylcytosine | 1 | 2013 | 152 | 0.110 |
Why?
|
| Survival Analysis | 8 | 2018 | 10251 | 0.110 |
Why?
|
| Breast Neoplasms | 7 | 2019 | 20827 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2021 | 1344 | 0.110 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 890 | 0.110 |
Why?
|
| Blister | 1 | 2012 | 86 | 0.110 |
Why?
|
| Sarcoma, Myeloid | 1 | 2012 | 59 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2012 | 45 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3134 | 0.100 |
Why?
|
| Retroperitoneal Space | 1 | 2012 | 176 | 0.100 |
Why?
|
| Base Pair Mismatch | 1 | 2012 | 97 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2019 | 1678 | 0.100 |
Why?
|
| Pouchitis | 1 | 2012 | 62 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2015 | 894 | 0.100 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2013 | 1770 | 0.100 |
Why?
|
| Abdominal Pain | 2 | 2016 | 1064 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2018 | 766 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 250 | 0.100 |
Why?
|
| Endothelial Cells | 4 | 2022 | 3482 | 0.100 |
Why?
|
| Disease Progression | 8 | 2018 | 13273 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 944 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 471 | 0.100 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2011 | 83 | 0.100 |
Why?
|
| Colon | 2 | 2013 | 1772 | 0.100 |
Why?
|
| Exons | 3 | 2013 | 2438 | 0.100 |
Why?
|
| Receptors, CCR4 | 1 | 2011 | 81 | 0.100 |
Why?
|
| Animals | 24 | 2023 | 168660 | 0.100 |
Why?
|
| Gene Dosage | 5 | 2017 | 1252 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2021 | 3480 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2017 | 728 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2016 | 5445 | 0.100 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 599 | 0.100 |
Why?
|
| Colonic Pouches | 1 | 2012 | 121 | 0.100 |
Why?
|
| Carcinoma, Merkel Cell | 2 | 2018 | 303 | 0.100 |
Why?
|
| Cilia | 1 | 2014 | 464 | 0.090 |
Why?
|
| Mice | 20 | 2023 | 81154 | 0.090 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 717 | 0.090 |
Why?
|
| Jejunum | 1 | 2013 | 480 | 0.090 |
Why?
|
| Appendectomy | 1 | 2013 | 401 | 0.090 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 154 | 0.090 |
Why?
|
| HMGB Proteins | 2 | 2007 | 45 | 0.090 |
Why?
|
| Chordoma | 1 | 2014 | 359 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2012 | 202 | 0.090 |
Why?
|
| Diagnostic Errors | 2 | 2011 | 1256 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 1429 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2017 | 711 | 0.090 |
Why?
|
| Co-Repressor Proteins | 1 | 2011 | 194 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2016 | 506 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2020 | 3524 | 0.090 |
Why?
|
| Bacteria | 1 | 2021 | 2112 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 390 | 0.090 |
Why?
|
| Advisory Committees | 1 | 2015 | 775 | 0.090 |
Why?
|
| Liver | 2 | 2017 | 7479 | 0.090 |
Why?
|
| Antigens, CD | 2 | 2014 | 4026 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2016 | 606 | 0.090 |
Why?
|
| Antibodies, Neoplasm | 1 | 2012 | 286 | 0.090 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2012 | 189 | 0.090 |
Why?
|
| Receptors, Estrogen | 3 | 2021 | 2190 | 0.090 |
Why?
|
| Polyps | 1 | 2012 | 189 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2013 | 389 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 322 | 0.090 |
Why?
|
| Radiotherapy | 2 | 2016 | 1533 | 0.090 |
Why?
|
| Cell Respiration | 1 | 2010 | 199 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2020 | 2951 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 502 | 0.090 |
Why?
|
| Cohort Studies | 7 | 2021 | 40545 | 0.090 |
Why?
|
| Keratin-6 | 1 | 2009 | 18 | 0.090 |
Why?
|
| Esophagitis, Peptic | 1 | 2010 | 78 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2011 | 147 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2021 | 1898 | 0.090 |
Why?
|
| Pheochromocytoma | 1 | 2012 | 337 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2010 | 287 | 0.090 |
Why?
|
| Keratin-5 | 1 | 2009 | 46 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2011 | 367 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 323 | 0.090 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2011 | 104 | 0.090 |
Why?
|
| Astrocytoma | 1 | 2014 | 790 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 1352 | 0.090 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2008 | 252 | 0.090 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2011 | 180 | 0.090 |
Why?
|
| Giant Cell Tumors | 1 | 2009 | 99 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2016 | 1092 | 0.080 |
Why?
|
| Proton Pump Inhibitors | 2 | 2023 | 526 | 0.080 |
Why?
|
| Myeloid Cells | 2 | 2021 | 808 | 0.080 |
Why?
|
| Ossification, Heterotopic | 1 | 2012 | 239 | 0.080 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2013 | 387 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 2 | 2018 | 420 | 0.080 |
Why?
|
| Pyrazoles | 2 | 2010 | 1970 | 0.080 |
Why?
|
| Receptors, Complement 3d | 1 | 2009 | 118 | 0.080 |
Why?
|
| Receptors, Complement 3b | 1 | 2009 | 145 | 0.080 |
Why?
|
| Esophagoscopy | 3 | 2018 | 390 | 0.080 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2009 | 85 | 0.080 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2011 | 314 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4803 | 0.080 |
Why?
|
| Genes, p16 | 2 | 2021 | 157 | 0.080 |
Why?
|
| Immune System Diseases | 1 | 2011 | 261 | 0.080 |
Why?
|
| Subcutaneous Tissue | 1 | 2009 | 135 | 0.080 |
Why?
|
| Food Hypersensitivity | 2 | 2013 | 622 | 0.080 |
Why?
|
| Face | 1 | 2014 | 993 | 0.080 |
Why?
|
| Heart Neoplasms | 1 | 2012 | 374 | 0.080 |
Why?
|
| Hyalin | 1 | 2008 | 37 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 429 | 0.080 |
Why?
|
| Chromogranins | 1 | 2009 | 163 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2010 | 657 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2013 | 576 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2020 | 1946 | 0.080 |
Why?
|
| Proportional Hazards Models | 5 | 2017 | 12354 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2011 | 675 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1903 | 0.080 |
Why?
|
| Incidental Findings | 2 | 2012 | 689 | 0.080 |
Why?
|
| Glioma | 2 | 2021 | 3401 | 0.080 |
Why?
|
| Ectodermal Dysplasia | 1 | 2009 | 106 | 0.080 |
Why?
|
| Epitopes | 1 | 2014 | 2570 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3566 | 0.080 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 715 | 0.080 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2009 | 528 | 0.080 |
Why?
|
| Cell Membrane | 2 | 2007 | 3749 | 0.080 |
Why?
|
| Isoenzymes | 3 | 2013 | 1728 | 0.080 |
Why?
|
| Positron-Emission Tomography | 6 | 2014 | 6237 | 0.080 |
Why?
|
| Ankle | 1 | 2010 | 327 | 0.080 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2009 | 627 | 0.080 |
Why?
|
| Gardner Syndrome | 1 | 2007 | 4 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2018 | 2988 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 252 | 0.080 |
Why?
|
| Sepsis | 1 | 2021 | 2593 | 0.080 |
Why?
|
| Allergens | 2 | 2013 | 1320 | 0.070 |
Why?
|
| Plasma Cells | 1 | 2011 | 593 | 0.070 |
Why?
|
| Risk Factors | 10 | 2021 | 72252 | 0.070 |
Why?
|
| Respiratory System | 2 | 2021 | 557 | 0.070 |
Why?
|
| Neurofilament Proteins | 1 | 2009 | 318 | 0.070 |
Why?
|
| Genome, Human | 2 | 2017 | 4418 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2011 | 323 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2009 | 202 | 0.070 |
Why?
|
| RNA, Viral | 1 | 2015 | 2901 | 0.070 |
Why?
|
| Mannose-Binding Lectins | 1 | 2007 | 100 | 0.070 |
Why?
|
| Combined Modality Therapy | 6 | 2016 | 8637 | 0.070 |
Why?
|
| United States | 10 | 2021 | 69859 | 0.070 |
Why?
|
| Embryonic Stem Cells | 3 | 2013 | 1295 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 2010 | 541 | 0.070 |
Why?
|
| Fetal Blood | 1 | 2013 | 1318 | 0.070 |
Why?
|
| DNA Repair Enzymes | 1 | 2008 | 349 | 0.070 |
Why?
|
| Immunization | 1 | 2011 | 1255 | 0.070 |
Why?
|
| Synovial Membrane | 1 | 2009 | 506 | 0.070 |
Why?
|
| Autopsy | 2 | 2020 | 1020 | 0.070 |
Why?
|
| Cytogenetics | 2 | 2021 | 203 | 0.070 |
Why?
|
| Papillomavirus Infections | 2 | 2015 | 1587 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2014 | 1247 | 0.070 |
Why?
|
| Bone and Bones | 2 | 2017 | 2576 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2211 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 90 | 0.070 |
Why?
|
| Registries | 2 | 2019 | 8090 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2021 | 25609 | 0.070 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2010 | 450 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 2110 | 0.070 |
Why?
|
| Germinoma | 1 | 2006 | 134 | 0.070 |
Why?
|
| Vaccination | 2 | 2022 | 3275 | 0.070 |
Why?
|
| Thyroidectomy | 1 | 2011 | 879 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2021 | 2749 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2021 | 6535 | 0.070 |
Why?
|
| Genes, erbB-1 | 1 | 2006 | 161 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2013 | 3000 | 0.070 |
Why?
|
| Hemangiopericytoma | 1 | 2006 | 77 | 0.070 |
Why?
|
| Pyridines | 3 | 2015 | 2827 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13980 | 0.070 |
Why?
|
| Necrosis | 2 | 2022 | 1642 | 0.070 |
Why?
|
| Immunophenotyping | 4 | 2016 | 1880 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2019 | 185 | 0.060 |
Why?
|
| Exocrine Glands | 1 | 2005 | 50 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2018 | 5096 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2007 | 263 | 0.060 |
Why?
|
| Myxoma | 1 | 2006 | 130 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2009 | 547 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2009 | 1536 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 6380 | 0.060 |
Why?
|
| Signal Transduction | 6 | 2018 | 23398 | 0.060 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 805 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.060 |
Why?
|
| Pyrroles | 2 | 2012 | 1147 | 0.060 |
Why?
|
| Genomics | 2 | 2018 | 5714 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2017 | 188 | 0.060 |
Why?
|
| Salvage Therapy | 1 | 2011 | 1275 | 0.060 |
Why?
|
| DNA Glycosylases | 2 | 2017 | 128 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1832 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2012 | 2566 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 2134 | 0.060 |
Why?
|
| Proteins | 1 | 2019 | 6098 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2007 | 589 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2023 | 91 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 1613 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 1350 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2022 | 2850 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2016 | 5021 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 1151 | 0.060 |
Why?
|
| Recurrence | 2 | 2016 | 8337 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2217 | 0.050 |
Why?
|
| Indoles | 2 | 2012 | 1841 | 0.050 |
Why?
|
| Pancreatectomy | 2 | 2018 | 804 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 1837 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2703 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2018 | 844 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2013 | 4561 | 0.050 |
Why?
|
| Prevalence | 4 | 2021 | 15211 | 0.050 |
Why?
|
| Smad4 Protein | 1 | 2023 | 163 | 0.050 |
Why?
|
| DNA Repair | 1 | 2012 | 2045 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1620 | 0.050 |
Why?
|
| Contrast Media | 5 | 2014 | 5301 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2022 | 191 | 0.050 |
Why?
|
| Azepines | 2 | 2014 | 334 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2013 | 2915 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1999 | 6311 | 0.050 |
Why?
|
| Mediastinal Neoplasms | 1 | 2005 | 423 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 26 | 0.050 |
Why?
|
| Observer Variation | 3 | 2014 | 2592 | 0.050 |
Why?
|
| Mitosis | 1 | 2007 | 1207 | 0.050 |
Why?
|
| Papio papio | 1 | 2021 | 3 | 0.050 |
Why?
|
| Tendons | 1 | 2006 | 548 | 0.050 |
Why?
|
| Neurofibromin 2 | 1 | 2022 | 267 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 2865 | 0.050 |
Why?
|
| DNA Copy Number Variations | 2 | 2021 | 1937 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6356 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 2248 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 402 | 0.050 |
Why?
|
| Crohn Disease | 2 | 2011 | 2304 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2015 | 5179 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2010 | 1287 | 0.050 |
Why?
|
| Ovalbumin | 2 | 2013 | 719 | 0.050 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2019 | 27 | 0.050 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2020 | 88 | 0.050 |
Why?
|
| Paris | 1 | 2019 | 42 | 0.050 |
Why?
|
| Carcinoma, Ductal | 1 | 2020 | 101 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 435 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2022 | 323 | 0.040 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2021 | 165 | 0.040 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 75 | 0.040 |
Why?
|
| Administration, Cutaneous | 2 | 2013 | 710 | 0.040 |
Why?
|
| Pregnancy | 4 | 2022 | 29140 | 0.040 |
Why?
|
| Consensus | 2 | 2021 | 2954 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2177 | 0.040 |
Why?
|
| Cholera Toxin | 2 | 2013 | 556 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2720 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2014 | 9139 | 0.040 |
Why?
|
| Fetal Death | 1 | 2021 | 448 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 3583 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 449 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2022 | 530 | 0.040 |
Why?
|
| Hypocalcemia | 1 | 2020 | 191 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2021 | 980 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 915 | 0.040 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2020 | 151 | 0.040 |
Why?
|
| Probability | 1 | 2004 | 2505 | 0.040 |
Why?
|
| Adenomatous Polyps | 1 | 2019 | 107 | 0.040 |
Why?
|
| Triazoles | 2 | 2014 | 904 | 0.040 |
Why?
|
| Multivariate Analysis | 4 | 2014 | 12243 | 0.040 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 18027 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2008 | 1938 | 0.040 |
Why?
|
| Cell Aggregation | 1 | 2018 | 244 | 0.040 |
Why?
|
| Capillaries | 2 | 2019 | 773 | 0.040 |
Why?
|
| Biotinylation | 1 | 1998 | 179 | 0.040 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2020 | 252 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2006 | 2615 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2012 | 799 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 2646 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 1998 | 254 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2018 | 14563 | 0.040 |
Why?
|
| Breast | 1 | 2007 | 1970 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2021 | 53250 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 427 | 0.040 |
Why?
|
| Succinic Acid | 1 | 2018 | 82 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.040 |
Why?
|
| Hepatomegaly | 1 | 2017 | 85 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1998 | 421 | 0.040 |
Why?
|
| Fumarates | 1 | 2018 | 132 | 0.040 |
Why?
|
| Animal Feed | 1 | 2017 | 110 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 265 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 968 | 0.040 |
Why?
|
| Knee Joint | 1 | 2006 | 1680 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1998 | 2327 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2007 | 1887 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2017 | 190 | 0.040 |
Why?
|
| Prednisone | 2 | 2011 | 1574 | 0.040 |
Why?
|
| Color | 1 | 2018 | 304 | 0.040 |
Why?
|
| Phosphates | 1 | 2020 | 784 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 2018 | 271 | 0.040 |
Why?
|
| Thiolester Hydrolases | 1 | 2017 | 86 | 0.040 |
Why?
|
| Foot | 1 | 2020 | 527 | 0.040 |
Why?
|
| Glutarates | 1 | 2018 | 236 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 838 | 0.030 |
Why?
|
| Pandemics | 3 | 2021 | 8385 | 0.030 |
Why?
|
| Anal Canal | 1 | 2019 | 376 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2019 | 350 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2015 | 38 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 2016 | 141 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 2217 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 903 | 0.030 |
Why?
|
| Computational Biology | 2 | 2018 | 3515 | 0.030 |
Why?
|
| Infarction | 1 | 2017 | 244 | 0.030 |
Why?
|
| U937 Cells | 1 | 2015 | 268 | 0.030 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2015 | 59 | 0.030 |
Why?
|
| Automation, Laboratory | 1 | 2015 | 101 | 0.030 |
Why?
|
| Choline | 1 | 2017 | 492 | 0.030 |
Why?
|
| Cofilin 2 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2021 | 2725 | 0.030 |
Why?
|
| Age Factors | 3 | 2021 | 18355 | 0.030 |
Why?
|
| Neutrophils | 2 | 2021 | 3718 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 3547 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1013 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 21824 | 0.030 |
Why?
|
| Penetrance | 1 | 2017 | 381 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 2015 | 157 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 1862 | 0.030 |
Why?
|
| Immunotoxins | 1 | 1995 | 179 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2018 | 751 | 0.030 |
Why?
|
| Mice, Nude | 2 | 1999 | 3680 | 0.030 |
Why?
|
| Immunoassay | 1 | 1998 | 751 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 1404 | 0.030 |
Why?
|
| Syndrome | 2 | 2011 | 3249 | 0.030 |
Why?
|
| Methionine | 1 | 2017 | 590 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2016 | 4777 | 0.030 |
Why?
|
| Central Nervous System Cysts | 1 | 2014 | 58 | 0.030 |
Why?
|
| Forms and Records Control | 1 | 2015 | 160 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 1084 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1995 | 357 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 893 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2016 | 486 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 2016 | 546 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 169 | 0.030 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 503 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 3645 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 3794 | 0.030 |
Why?
|
| Lung | 1 | 2012 | 9858 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1320 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2015 | 622 | 0.030 |
Why?
|
| Anti-Allergic Agents | 1 | 2015 | 141 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2018 | 8316 | 0.030 |
Why?
|
| Interleukins | 1 | 2018 | 791 | 0.030 |
Why?
|
| Antibodies | 2 | 2013 | 2459 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2018 | 594 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 873 | 0.030 |
Why?
|
| Data Mining | 1 | 2018 | 537 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 618 | 0.030 |
Why?
|
| Calcinosis | 1 | 2002 | 1495 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9377 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1656 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 26345 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2014 | 147 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2015 | 3740 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2008 | 3480 | 0.030 |
Why?
|
| Injections | 1 | 2016 | 839 | 0.030 |
Why?
|
| Neurofibromin 1 | 1 | 2014 | 196 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1995 | 326 | 0.030 |
Why?
|
| Genes, ras | 1 | 2016 | 690 | 0.030 |
Why?
|
| Cytological Techniques | 1 | 2014 | 219 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 1996 | 798 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 781 | 0.030 |
Why?
|
| Salivary Glands | 1 | 2014 | 229 | 0.030 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2012 | 26 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 2504 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 4320 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 1787 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1366 | 0.030 |
Why?
|
| Cromolyn Sodium | 1 | 2012 | 87 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 2256 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2018 | 902 | 0.030 |
Why?
|
| Diaphragm | 1 | 2014 | 349 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2012 | 6457 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 348 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 592 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 215 | 0.030 |
Why?
|
| Monocytes | 1 | 2021 | 2593 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2014 | 565 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 791 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 590 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2012 | 136 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2020 | 1102 | 0.030 |
Why?
|
| Epinephrine | 1 | 2015 | 792 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 738 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 646 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 5033 | 0.020 |
Why?
|
| Vimentin | 1 | 2012 | 262 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 375 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1782 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2016 | 5986 | 0.020 |
Why?
|
| Flushing | 1 | 2011 | 48 | 0.020 |
Why?
|
| Buttocks | 1 | 2011 | 110 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 169 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2015 | 543 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 13809 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2011 | 143 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2011 | 226 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 3874 | 0.020 |
Why?
|
| Reference Standards | 1 | 2015 | 1023 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2011 | 228 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 1917 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2011 | 278 | 0.020 |
Why?
|
| Factor VIII | 1 | 2013 | 347 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2015 | 593 | 0.020 |
Why?
|
| Workflow | 1 | 2015 | 847 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2012 | 231 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3580 | 0.020 |
Why?
|
| Lymphoma | 2 | 2016 | 1875 | 0.020 |
Why?
|
| Depression | 1 | 2010 | 7760 | 0.020 |
Why?
|
| Adrenal Glands | 1 | 2013 | 547 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2010 | 69 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2011 | 287 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 620 | 0.020 |
Why?
|
| Desensitization, Immunologic | 1 | 2015 | 483 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2012 | 467 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2011 | 318 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2011 | 588 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1998 | 2378 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 10179 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 2560 | 0.020 |
Why?
|
| Hypertension | 1 | 2010 | 8480 | 0.020 |
Why?
|
| Fibrosis | 1 | 2017 | 2030 | 0.020 |
Why?
|
| Alphapapillomavirus | 1 | 2013 | 221 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1157 | 0.020 |
Why?
|
| Niacinamide | 1 | 2012 | 416 | 0.020 |
Why?
|
| Shoulder | 1 | 2012 | 299 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 338 | 0.020 |
Why?
|
| Body Temperature | 1 | 2013 | 774 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 334 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 2012 | 609 | 0.020 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 1029 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2015 | 15518 | 0.020 |
Why?
|
| Vincristine | 1 | 2011 | 1039 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2015 | 8436 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 1729 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1996 | 901 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2013 | 1147 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2006 | 3701 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2015 | 2226 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 2013 | 590 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4204 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1705 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 987 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 528 | 0.020 |
Why?
|
| CA-125 Antigen | 1 | 2011 | 286 | 0.020 |
Why?
|
| Fluconazole | 1 | 2009 | 146 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2009 | 219 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 757 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 1463 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 365 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2008 | 180 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 1098 | 0.020 |
Why?
|
| International Cooperation | 1 | 2015 | 1419 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13404 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2011 | 492 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 847 | 0.020 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 99 | 0.020 |
Why?
|
| Leukemia | 1 | 2016 | 1509 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2012 | 536 | 0.020 |
Why?
|
| Exanthema | 1 | 2012 | 501 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1940 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2014 | 2879 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1783 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2014 | 1485 | 0.020 |
Why?
|
| Giant Cells | 1 | 2008 | 187 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2011 | 384 | 0.020 |
Why?
|
| Azithromycin | 1 | 2009 | 196 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8939 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2009 | 387 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2013 | 3690 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 959 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 3622 | 0.020 |
Why?
|
| Cyclin D | 1 | 2007 | 72 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1794 | 0.020 |
Why?
|
| Antigens | 1 | 2013 | 1466 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2883 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 319 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5881 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 612 | 0.020 |
Why?
|
| Endometriosis | 1 | 2014 | 838 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 5445 | 0.020 |
Why?
|
| Dermis | 1 | 2008 | 207 | 0.020 |
Why?
|
| Integrins | 1 | 2011 | 846 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 579 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 2638 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 1639 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2011 | 2123 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2890 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2008 | 371 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5078 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 788 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 2796 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2712 | 0.020 |
Why?
|
| Lipids | 1 | 2017 | 3307 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2011 | 2241 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 2617 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 2008 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2007 | 223 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 1662 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2011 | 2234 | 0.020 |
Why?
|
| CpG Islands | 1 | 2009 | 1170 | 0.020 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 2004 | 52 | 0.020 |
Why?
|
| Quinazolines | 1 | 2011 | 1356 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2008 | 391 | 0.020 |
Why?
|
| Monosomy | 1 | 2004 | 54 | 0.020 |
Why?
|
| Cyclins | 1 | 2007 | 603 | 0.020 |
Why?
|
| Antigens, CD1 | 1 | 2007 | 437 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 1095 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2009 | 652 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2009 | 729 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 2131 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2011 | 1705 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4931 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1851 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 1854 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1674 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 866 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 623 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2011 | 3912 | 0.010 |
Why?
|
| Methylation | 1 | 2006 | 1104 | 0.010 |
Why?
|
| Cell Line | 2 | 2014 | 15993 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2963 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3463 | 0.010 |
Why?
|
| Remission Induction | 1 | 2008 | 2384 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2011 | 1629 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 1152 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2011 | 1066 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 583 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2011 | 2107 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2002 | 142 | 0.010 |
Why?
|
| Activin Receptors, Type II | 1 | 2002 | 127 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 971 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2013 | 3280 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2013 | 2958 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9731 | 0.010 |
Why?
|
| Alleles | 1 | 2011 | 6934 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1580 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2692 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5216 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1789 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10394 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 7930 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12066 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 2007 | 880 | 0.010 |
Why?
|
| Cytokines | 1 | 2013 | 7324 | 0.010 |
Why?
|
| Genome | 1 | 2006 | 1806 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7270 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3320 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2009 | 9848 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2715 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 4152 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10940 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1996 | 307 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 20948 | 0.010 |
Why?
|
| Homeostasis | 1 | 2006 | 3337 | 0.010 |
Why?
|
| Disease Management | 1 | 2003 | 2459 | 0.010 |
Why?
|
| Drug Carriers | 1 | 1995 | 690 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7172 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 12798 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 18107 | 0.000 |
Why?
|